Evidence map›Paper›PMID 26510966›Full record

ArticleInternational journal of impotence research

Factors predicting outcomes of penile rehabilitation with udenafil 50 mg following radical prostatectomy.

T-H Kim, Y-S Ha, S H Choi, E S Yoo, B W Kim, S-J Yun, W-J Kim, Y S Kwon, T G Kwon

Erratum issuedAbstract read
PubMed Publisher
In one paragraph

Article in International journal of impotence research. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

T-H KimDepartment of Urology, School of Medicine, Kyungpook National University, Daegu, South Korea.
Y-S HaDepartment of Urology, School of Medicine, Chilgok Kyungpook National University, Daegu, South Korea.
S H ChoiDepartment of Urology, School of Medicine, Chilgok Kyungpook National University, Daegu, South Korea.
E S YooDepartment of Urology, School of Medicine, Chilgok Kyungpook National University, Daegu, South Korea.
B W KimDepartment of Urology, School of Medicine, Chilgok Kyungpook National University, Daegu, South Korea.
S-J YunDepartment of Urology, College of Medicine, Chungbuk National University, Cheongju, Chungbuk, South Korea.
W-J KimDepartment of Urology, College of Medicine, Chungbuk National University, Cheongju, Chungbuk, South Korea.
Y S KwonSection of Urologic Oncology, Rutgers Cancer Institute of New Jersey and Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA.
T G KwonDepartment of Urology, School of Medicine, Chilgok Kyungpook National University, Daegu, South Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Udenafil is a selective phosphodiesterase type 5 inhibitor made available in recent years for the treatment of erectile dysfunction. Herein, we evaluated independent predictors of potency recovery in radical prostatectomy (RP) patients who underwent penile rehabilitation with udenafil 50 mg. One hundred and forty-three men who underwent RP were enrolled in a penile rehabilitation program using udenafil 50 mg every other day. The rate of regained potency in the study group was significantly higher compared with the recovery rate seen in patients who were not part of the penile rehabilitation program (41.3% vs 13.0%; P<0.001). On the multivariate Cox analyses, preoperative International Index of Erectile Function-5 scores (hazard ratio (HR), 1.049; P=0.040), alcohol consumption (HR, 2.043; P=0.020) and Gleason biopsy score (HR, 0.368; P=0.024) were independent preoperative predictors for potency recovery. Among post-RP variables, the use of robotic procedures (HR, 2.287; P=0.030) and pathologic stage (HR, 0.506; P=0.038) were significantly associated with potency recovery. This study identified predictive factors for the recovery of potency in patients undergoing penile rehabilitation with udenafil following RP. Our results could provide physicians with useful information for counseling RP patients and selecting optimal candidates for penile rehabilitation.

Indexed as

Erectile DysfunctionPostoperative ComplicationsAgedBenzenesulfonamidesHumansMaleMiddle AgedPhosphodiesterase 5 InhibitorsPrognosisProstatectomyProstatic NeoplasmsPyrimidinesRecovery of FunctionRepublic of KoreaRisk FactorsSulfonamidesBenzenesulfonamidesPhosphodiesterase 5 InhibitorsPyrimidinesSulfonamidesudenafil

Identifiers

PMID26510966

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.